These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Hereditary tyrosinaemia type II in a consanguineous Ashkenazi Jewish family: intrafamilial variation in phenotype; absence of parental phenotype effects on the fetus. Chitayat D; Balbul A; Hani V; Mamer OA; Clow C; Scriver CR J Inherit Metab Dis; 1992; 15(2):198-203. PubMed ID: 1356171 [TBL] [Abstract][Full Text] [Related]
52. Unravelling 5-oxoprolinuria (pyroglutamic aciduria) due to bi-allelic OPLAH mutations: 20 new mutations in 14 families. Sass JO; Gemperle-Britschgi C; Tarailo-Graovac M; Patel N; Walter M; Jordanova A; Alfadhel M; Barić I; Çoker M; Damli-Huber A; Faqeih EA; García Segarra N; Geraghty MT; Jåtun BM; Kalkan Uçar S; Kriewitz M; Rauchenzauner M; Bilić K; Tournev I; Till C; Sayson B; Beumer D; Ye CX; Zhang LH; Vallance H; Alkuraya FS; van Karnebeek CD Mol Genet Metab; 2016 Sep; 119(1-2):44-9. PubMed ID: 27477828 [TBL] [Abstract][Full Text] [Related]
53. Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity. Labelle Y; Phaneuf D; Leclerc B; Tanguay RM Hum Mol Genet; 1993 Jul; 2(7):941-6. PubMed ID: 8364576 [TBL] [Abstract][Full Text] [Related]
54. Improvement of oxidized glutathione fermentation by thiol redox metabolism engineering in Saccharomyces cerevisiae. Hara KY; Aoki N; Kobayashi J; Kiriyama K; Nishida K; Araki M; Kondo A Appl Microbiol Biotechnol; 2015 Nov; 99(22):9771-8. PubMed ID: 26239069 [TBL] [Abstract][Full Text] [Related]
55. Selective modification of glutathione metabolism. Meister A Science; 1983 Apr; 220(4596):472-7. PubMed ID: 6836290 [TBL] [Abstract][Full Text] [Related]
56. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lindstedt S; Holme E; Lock EA; Hjalmarson O; Strandvik B Lancet; 1992 Oct; 340(8823):813-7. PubMed ID: 1383656 [TBL] [Abstract][Full Text] [Related]
57. Hepatic tyrosine aminotransferase in tyrosinaemia type II. Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036 [No Abstract] [Full Text] [Related]
58. Ethanol-induced changes of intracellular thiol compartmentation and protein redox status in the rat liver: effect of tauroursodeoxycholate. Vendemiale G; Grattagliano I; Signorile A; Altomare E J Hepatol; 1998 Jan; 28(1):46-53. PubMed ID: 9537863 [TBL] [Abstract][Full Text] [Related]
59. Increased excretion of coproporphyrin I in a patient with hereditary tyrosinaemia type I: relevant changes with NTBC treatment. Depetris-Boldini C; Galetto R; Videla MP; de Kremer Dodelson R J Inherit Metab Dis; 1999 May; 22(3):227-30. PubMed ID: 10384374 [No Abstract] [Full Text] [Related]
60. Neonatal and prenatal diagnosis of hereditary tyrosinaemia. King GS; MacKenzie F; Pettit BR Lancet; 1983 Jun; 1(8336):1279. PubMed ID: 6134070 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]